XML 134 R90.htm IDEA: XBRL DOCUMENT v3.23.1
OTHER LIABILITIES - Disclosure Of Detailed Information About Other Liabilities - Narrative (Details)
2 Months Ended 12 Months Ended 21 Months Ended
Apr. 15, 2021
USD ($)
shares
Apr. 15, 2021
shares
$ / shares
Apr. 14, 2021
USD ($)
Apr. 07, 2021
USD ($)
shares
Apr. 07, 2021
shares
$ / shares
Mar. 14, 2023
USD ($)
Dec. 31, 2022
USD ($)
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
shares
Dec. 31, 2022
USD ($)
shares
Dec. 31, 2022
USD ($)
shares
Jan. 01, 2023
USD ($)
shares
Oct. 18, 2021
USD ($)
Disclosure of contingent liabilities [line items]                          
Number of securities called by warrant (in shares) | shares       1 1                
Hold period             4 months            
Share-based compensation arrangement by share-based payment award, percentage of outstanding warrant liability       40.00%                  
Share-based compensation arrangement by share-based payment award, outstanding of premier warrants (in shares) | shares       2,000,000.0                  
Class of warrant or right, issued for company settlement (in shares) | shares       800,000                  
Fair value adjustments of warrants             $ 0   $ 800,000   $ 500,000    
Loss on warrants             1,040,000   2,515,000        
Share-based payment liability             $ 983,000 $ 983,000 0 $ 983,000 983,000    
Deferred consideration                 42,543,000        
Osgood Mining Company LLC                          
Disclosure of contingent liabilities [line items]                          
Number of other equity instruments issued in sharebased payment arrangement (in shares) | shares             350,000            
Number of securities called by warrant (in shares) | shares 1 1                      
Weighted average exercise price of other equity instruments issued in sharebased payment arrangement (In CAD per share) | $ / shares   $ 3.64                      
Hold period 4 months                        
Fair value adjustments of warrants $ 6,100,000           $ 10,100,000   8,900,000        
Warrants issued (in shares)     $ 12,100,000                    
Shares issued from exercise of warrants (in shares) | shares             350,000            
RSUs and DSUs                          
Disclosure of contingent liabilities [line items]                          
Current portion of liabilities from share-based payment transactions             $ 400,000 $ 400,000 0 400,000 400,000    
Share Purchase Warrants                          
Disclosure of contingent liabilities [line items]                          
Number of other equity instruments issued in sharebased payment arrangement (in shares) | shares       7,730,000                  
Weighted average exercise price of other equity instruments issued in sharebased payment arrangement (In CAD per share) | $ / shares               $ 3.64          
Hold period             4 months            
Class of warrants or rights issued in consideration for warrants recognized       $ 2,900,000     $ 0   2,200,000        
Ruby Hill, Nevada                          
Disclosure of contingent liabilities [line items]                          
Deferred consideration             45,805,000 $ 45,805,000 42,500,000 45,805,000 $ 45,805,000   $ 41,900,000
Gains (losses) on financial liabilities at fair value through profit or loss             (3,300,000)            
Payments of deferred compensation           $ 27,000,000.0              
Total consideration                       $ 11,000,000.0  
Business acquisition, equity interest issued or issuable (in shares) | shares                       5,515,313  
Financing Agreements                          
Disclosure of contingent liabilities [line items]                          
Weighted average exercise price of other equity instruments issued in sharebased payment arrangement (In CAD per share) | $ / shares         $ 3.275                
Fair value adjustments of warrants             $ 5,900,000   $ 3,500,000 $ 3,500,000      
Warrants issued for financing arrangement (in shares) | shares       5,500,000                  
Exercise period of warrants       36 months                  
Warrant liability                          
Disclosure of contingent liabilities [line items]                          
Number of warrants outstanding (in shares) | shares             17,561,152 17,561,152 26,099,806 17,561,152 17,561,152